Latest News and Press Releases

STOCKHOLM, Sweden, Oct. 06, 2005 (PRIMEZONE) -- Biovitrum's project portfolio has developed very positively during 2005. It has today several projects in or near clinical phase within diabetes,...

STOCKHOLM, Sweden, Sept. 13, 2005 (PRIMEZONE) -- The glaucoma candidate drug (BVT.28949) has been internally developed within Biovitrum and the first clinical study for safety testing was entered in...

STOCKHOLM, Sweden, Aug. 22, 2005 (PRIMEZONE) -- Biovitrum expands the project portfolio with projects in clinical phase, both I and II, together with additional preclinical projects within its...

STOCKHOLM, Sweden, Aug. 17, 2005 (PRIMEZONE) -- Biovitrum AB, Sweden, and Swiss-based Santhera Pharmaceuticals AG have signed a license and collaboration agreement that grants Biovitrum the exclusive...

STOCKHOLM, Sweden, May 31, 2005 (PRIMEZONE) -- Biovitrum AB and Karolinska Institutet (KI) have signed an agreement implicating that Biovitrum Biopharmaceuticals on behalf of the Department of Woman...

STOCKHOLM, Sweden, April 25, 2005 (PRIMEZONE) -- An extra annual general meeting of the shareholders in Biovitrum AB has taken the formal decisions required to complete the acquisition of Cambridge...

STOCKHOLM, Sweden, April 18, 2005 (PRIMEZONE) -- Maria Berggren has been recruited as the new Vice President Human Resources at Biovitrum. Maria will be a member of the senior management team and...

STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Diamyd Medical AB and Biovitrum AB have signed an agreement covering the market adaptation of the production process for GAD65, Diamyd's product for...

STOCKHOLM, Sweden, March 21, 2005 (PRIMEZONE) -- Biovitrum today announces that the company has agreed to acquire Cambridge Biotechnology Ltd ("CBT"), a Cambridge UK based private drug discovery...

STOCKHOLM, Sweden, Jan. 26, 2005 (PRIMEZONE) -- Anna Karin Kallen has been recruited to the position of Vice President of Communications at Biovitrum. Anna Karin will be a member of the senior...